• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Levita Magnetics wins FDA clearance for magnetic-assisted surgical robot

Levita Magnetics wins FDA clearance for magnetic-assisted surgical robot

August 22, 2023 By Sean Whooley

Levita MARS magnetic assisted surgical robot system
The MARS surgical robot system. [Image courtesy of Levita Magnetics]
Levita Magnetics announced today that the FDA approved its MARS magnetic-assisted robotic surgery platform.

Mountain View, California-based Levita designed its MARS minimally invasive surgical platform for the high-volume abdominal surgery market. It combines magnets and machines to reduce the number of incisions, enabling complete control during laparoscopic procedures.

The system comes in a compact footprint designed to fit into existing operating rooms. It builds on the success of the company’s first commercial product, the Levita Magnetic Surgical System. Levita designed MARS to deliver the same patient benefits while empowering surgeons with increased control of surgical instruments.

“Today marks a significant milestone in Levita’s mission to provide more patients access to state-of-the-art surgical technology. MARS is poised to revolutionize surgical options for a broad range of patients,” said Dr. Alberto Rodriguez-Navarro, surgeon, founder, and CEO of Levita Magnetics. “With this FDA clearance, we eagerly anticipate making a substantial impact across the value chain.”

Levita was included in MassDevice’s 2022 list of surgical robotics companies you need to know. Read here.

More about the Levita MARS system

According to the company, it designed MARS to deliver a “triple impact.” The company hopes for patients to experience less-invasive surgery with reduced incisions. This results in less pain, faster recovery and fewer scars.

Meanwhile, surgeons benefit from a system that provides full control in multiple facets. They can control the laparoscopic view, reducing the need for an additional assistant. Additionally, the control of the Magnetic Surgical System enables the retraction of large tissues and organs, including the liver, gallbladder, prostate and colon.

Levita said that hospitals and ambulatory surgery centers can benefit from increased efficiency, too. They’ll also reap the rewards of more effective OR personnel deployment and a differentiated patient procedure.

“MARS by Levita has the potential to reshape the surgical industry and forever change medical innovation. Our pioneering MARS platform gives patients and surgeons a transformative tool that will usher in a fundamental shift in surgery for years to come,” said Chair Maria Sainz. “Levita’s system can aid in surgeon proficiency and efficiency, and can reduce the need for assistive personnel, signaling a major achievement not only for Levita but for surgical care.”

Filed Under: 510(k), Food & Drug Administration (FDA), Health Technology, Regulatory/Compliance, Surgical, Surgical Robotics Tagged With: Levita Magnetics

More recent news

  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring
  • Boston Scientific MedSurg, Asia Pacific leader to retire
  • DePuy Synthes launches next-generation automated fracture fixation system

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy